Top

Reactions Weekly

Published in:

01-08-2022 | Pravastatin | Case report

Rosuvastatin/tafamidis meglumine interaction

First report of myalgia: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* Drug interaction

…

Lasse A, et al. Related muscle toxicity with concurrent use of tafamidis and rosuvastatine: Which mechanism?. Fundamental and Clinical Pharmacology 36 (Suppl. 1): 150-151 abstr. PS-109, Jun 2022. Available from: URL: http://doi.org/10.1111/fcp.12789

Title: Rosuvastatin/tafamidis meglumine interaction
First report of myalgia: case report
Publication date: 01-08-2022
Publisher: Springer International Publishing
Keywords: Pravastatin
Myalgie
Myalgia
Cardiac Amyloidosis
Rosuvastatin
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-21482-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rosuvastatin/tafamidis meglumine interaction

First report of myalgia: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Gammaglobulin/methylprednisolone

Infliximab

Alprazolam overdose

Anti infectives/leflunomide/methylprednisolone

Carbamazepine

Isotretinoin